Use a 1:1 Ratio When Switching from Insulin Degludec to Glargine or Detemir

January 2016

Insulin degludec (Tresiba, treh-SEE-bah) is a new once-daily ULTRA long-acting insulin.

It lasts about 42 hours...compared to about 24 hours for glargine (Lantus) or detemir (Levemir).

You may hear that degludec's longer duration means it doesn't need to be used at the same time every day.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Medication Errors Help Standardize Stock In Operating Rooms
Infection Prevention Verify Catheters are Removed in Your PostOperative Patients
Hypertension Don't "SPRINT" to a Systolic BP Goal of < 120
Naloxone Verify That Patients Will Benefit From Topical NSAIDs at Discharge
Hepatitis C Watch Closely for Drug Interactions with Hep C Meds
Cardiology Tell Patients Clopidogrel Doesn't Increase Mortality
Antibiotics Limit Quinolone Use Due to Side Effects
Neurology & Pain Verify That Patients Will Benefit From Topical NSAIDs at Discharge
Vaccines Don't Stop Statins in Patients Getting the Flu Vaccine
Asthma Give Single Dose Dexamethasone for Pediatric Asthma Exacerbations in the ED
Diabetes Use a 1:1 Ratio When Switching from Insulin Degludec to Glargine or Detemir
Hematology & Oncology Think of the Neurokinin-1 Antagonists as Equally Efficacious